Symington F W, Subbarao B, Mosier D E, Sprent J
Immunogenetics. 1982;16(5):381-91. doi: 10.1007/BF00372098.
A DBA/1 B10.D2-specific monoclonal antibody (CY34) is described which defines a new murine B lymphocyte differentiation antigen designated Lyb-8.2. The ontogeny, strain distribution, and cell-surface density of the antigen were studied by radioimmunoassay and by fluorescence-activated cell sorter (FACS) analysis. Lyb-8.2 appears to be expressed on pre-B cells and on all mature B lymphocytes. Lyb-8.2 molecules immunoprecipitated from surface labeled B10.D2 spleen cells migrated in polyacrylamide gels with an apparent mol. wt. of 95,000-105,000 daltons and were bound by lentil lectin. The expression of Lyb-8.2 is controlled by a locus on chromosome 7 that is closely linked to Gpi-1 and RP-2. Added Lyb-8.2-specific antibody did not measurably impair B lymphocyte function in several in vitro systems studied.
本文描述了一种DBA/1 B10.D2特异性单克隆抗体(CY34),它定义了一种新的小鼠B淋巴细胞分化抗原,命名为Lyb-8.2。通过放射免疫测定和荧光激活细胞分选仪(FACS)分析研究了该抗原的个体发生、品系分布和细胞表面密度。Lyb-8.2似乎在前B细胞和所有成熟B淋巴细胞上表达。从表面标记的B10.D2脾细胞免疫沉淀的Lyb-8.2分子在聚丙烯酰胺凝胶中迁移,表观分子量为95,000 - 105,000道尔顿,并与扁豆凝集素结合。Lyb-8.2的表达受7号染色体上一个与Gpi-1和RP-2紧密连锁的基因座控制。在所研究的几个体外系统中,添加Lyb-8.2特异性抗体并未显著损害B淋巴细胞功能。